https://medipharmlabs.com/about-us https://medipharmlabs.com/investors https://medipharmlabs.com/news https://medipharmlabs.com/products-and-services https://medipharmlabs.com/search https://medipharmlabs.com/email-alerts https://medipharmlabs.com/contact-us https://medipharmlabs.com/medipharm-labs-brand https://medipharmlabs.com/privacy-policy https://medipharmlabs.com/disclaimer https://medipharmlabs.com/terms-and-conditions https://medipharmlabs.com https://medipharmlabs.com/not-of-age https://medipharmlabs.com/sitemap https://medipharmlabs.com/careers https://medipharmlabs.com/vendor https://medipharmlabs.com/po-terms-and-conditions https://medipharmlabs.com/news-post/cbd-brand-of-the-year-medipharm-labs https://medipharmlabs.com/news-post/cbd-crystals-are-coming-to-canada https://medipharmlabs.com/news-post/cbds-range-of-applications-helps-reshape-public-opinion https://medipharmlabs.com/news-post/different-types-of-cannabinoids-explained https://medipharmlabs.com/news-post/first-quarter-2025-conference-call-webcast https://medipharmlabs.com/news-post/historic-u-s-cannabis-rescheduling-unlocks-potential-growth-opportunities-for-medipharm-labs-backed-by-the-companys-suite-of-licenses-and-proven-u-s-clinical-trial-supply-experience https://medipharmlabs.com/news-post/how-to-read-cannabis-labels-101 https://medipharmlabs.com/news-post/leading-independent-proxy-advisor-glass-lewis-recommends-shareholders-vote-the-green-proxy-for-all-medipharm-director-nominees https://medipharmlabs.com/news-post/leading-independent-proxy-advisor-iss-recommends-that-shareholders-vote-the-green-proxy-for-all-medipharm-director-nominees-rejects-apollos-arguments-and-director-slate-iss-concludes-that-apollo-has-not-presented-a-compelling-case-for-change https://medipharmlabs.com/news-post/medipharm-achieves-key-milestone-toward-4-5-million-cash-sale-of-hope-facility-on-track-to-close-in-june https://medipharmlabs.com/news-post/medipharm-advances-global-reach-in-q3-2025-with-double-digit-revenue-growth-and-strong-international-medical-cannabis-gains https://medipharmlabs.com/news-post/medipharm-announces-complete-dismissal-of-defamation-action-initiated-by-apollo-nobul-and-regan-mcgee-under-ontario-anti-slapp-law https://medipharmlabs.com/news-post/medipharm-announces-complete-dismissal-of-dissident-court-proceeding-related-to-annual-and-special-meeting https://medipharmlabs.com/news-post/medipharm-announces-voting-results-from-the-2025-annual-and-special-meeting-of-shareholders https://medipharmlabs.com/news-post/medipharm-cautions-shareholders-to-await-final-results-of-annual-and-special-meeting https://medipharmlabs.com/news-post/medipharm-labs-achieves-pharmaceutical-gmp-certification-with-brazilian-health-authority https://medipharmlabs.com/news-post/medipharm-labs-acquires-advanced-medical-cannabis-delivery-method-technology-from-remidose-aerosols https://medipharmlabs.com/news-post/medipharm-labs-alerts-shareholders-to-allegations-made-against-regan-mcgee-in-multiple-litigation-filings https://medipharmlabs.com/news-post/medipharm-labs-announces-2-1m-debt-repayment-company-now-materially-debt-free-with-over-13m-in-cash https://medipharmlabs.com/news-post/medipharm-labs-announces-board-of-directors-changes-shelley-potts-steps-down-michael-bumby-returns https://medipharmlabs.com/news-post/medipharm-labs-announces-ceo-transition-david-pidduck-to-step-down-cfo-greg-hunter-appointed-interim-ceo https://medipharmlabs.com/news-post/medipharm-labs-announces-changes-to-board-of-directors https://medipharmlabs.com/news-post/medipharm-labs-announces-departure-of-president-and-co-founder-keith-strachan https://medipharmlabs.com/news-post/medipharm-labs-announces-strong-q1-2025-results https://medipharmlabs.com/news-post/medipharm-labs-announces-termination-of-the-proposed-sale-of-napanee-facility-to-kensana-health https://medipharmlabs.com/news-post/medipharm-labs-announces-voting-results-from-the-2022-annual-meeting-of-shareholders https://medipharmlabs.com/news-post/medipharm-labs-appoints-new-chief-executive-officer https://medipharmlabs.com/news-post/medipharm-labs-awarded-payment-of-9-8m-in-connection-to-a-2020-statement-of-claim-against-a-previous-customer https://medipharmlabs.com/news-post/medipharm-labs-begins-production-of-first-order-for-international-expansion-of-novel-cannabis-metered-dose-portfolio-in-the-eu-and-united-kingdom-under-blackpoint-sales-and-distribution-agreement https://medipharmlabs.com/news-post/medipharm-labs-board-issues-letter-to-shareholders-in-response-to-inadequate-dissident-plan https://medipharmlabs.com/news-post/medipharm-labs-cautions-shareholders-about-dissident-nominees-governance-failures-at-check-cap-ltd https://medipharmlabs.com/news-post/medipharm-labs-closes-4-5-million-sale-of-hope-bc-facility-and-announces-plans-to-expand-eu-gmp-cultivation-capacity-at-napanee-facility https://medipharmlabs.com/news-post/medipharm-labs-completes-first-shipment-to-france https://medipharmlabs.com/news-post/medipharm-labs-completes-medical-cannabis-export-to-barbados https://medipharmlabs.com/news-post/medipharm-labs-completes-sale-of-australian-facility-for-proceeds-of-7-250-000-aud https://medipharmlabs.com/news-post/medipharm-labs-completes-sale-of-vacant-land-for-cash-proceeds-of-1-9-million https://medipharmlabs.com/news-post/medipharm-labs-continues-to-lead-with-innovation-launches-cbg-and-water-soluble-products https://medipharmlabs.com/news-post/medipharm-labs-corp-announces-mailing-and-filing-of-joint-circular-for-special-meeting-of-shareholders-to-approve-arrangement-with-vivo-cannabis-inc https://medipharmlabs.com/news-post/medipharm-labs-corp-completes-acquisition-of-vivo-cannabis-inc https://medipharmlabs.com/news-post/medipharm-labs-corp-to-acquire-vivo-cannabis-inc https://medipharmlabs.com/news-post/medipharm-labs-enters-cannabis-research-agreement-with-keck-school-of-medicine-of-usc https://medipharmlabs.com/news-post/medipharm-labs-enters-into-6-2m-purchase-agreement-for-the-sale-of-australian-facility https://medipharmlabs.com/news-post/medipharm-labs-enters-landmark-commercial-agreement-with-laboratorio-teuto-in-brazil https://medipharmlabs.com/news-post/medipharm-labs-enters-united-states-pharmaceutical-market-with-submission-of-fda-dmf https://medipharmlabs.com/news-post/medipharm-labs-expands-cbn-portfolio-with-two-new-products https://medipharmlabs.com/news-post/medipharm-labs-expands-leading-cbn-oil-portfolio-with-the-launch-of-new-nighttime-inhaler https://medipharmlabs.com/news-post/medipharm-labs-explains-erp-system-and-big-data https://medipharmlabs.com/news-post/medipharm-labs-files-proxy-materials-issues-chairs-letter-to-shareholders https://medipharmlabs.com/news-post/medipharm-labs-improves-domestic-sales-gross-margin-with-termination-of-shelter-cannabis-brands-royalty-agreement https://medipharmlabs.com/news-post/medipharm-labs-is-looking-to-capitalize-on-b2c-in-a-major-way-through-labs-cannabis https://medipharmlabs.com/news-post/medipharm-labs-launches-new-gmp-products-to-the-australian-medical-cannabis-market https://medipharmlabs.com/news-post/medipharm-labs-makes-first-delivery-of-cannabis-clinical-trial-material-to-us-research-partner-and-provides-update-on-us-fda-status https://medipharmlabs.com/news-post/medipharm-labs-names-experienced-pharma-and-med-tech-executive-david-pidduck-as-ceo https://medipharmlabs.com/news-post/medipharm-labs-positioned-for-unique-opportunities-on-possible-rescheduling-of-cannabis-in-the-united-states https://medipharmlabs.com/news-post/medipharm-labs-positioned-to-serve-growing-u-s-pharmaceutical-and-clinical-research-demand-following-cannabis-rescheduling https://medipharmlabs.com/news-post/medipharm-labs-provides-update-on-clinical-trial-progress-including-fda-approval-of-partner-study https://medipharmlabs.com/news-post/medipharm-labs-provides-update-on-german-cannabis-legalization https://medipharmlabs.com/news-post/medipharm-labs-provides-update-on-previously-announced-sale-of-napanee-facility-to-kensana-health https://medipharmlabs.com/news-post/medipharm-labs-provides-update-on-vivo-integration-and-board-appointee https://medipharmlabs.com/news-post/medipharm-labs-publishes-study-investigating-medical-cannabis-impacts-on-anxiety-and-depression-outcomes-in-fibromyalgia-patients https://medipharmlabs.com/news-post/medipharm-labs-raises-concerns-about-poorly-qualified-dissident-nominees https://medipharmlabs.com/news-post/medipharm-labs-receives-award-for-cbd-brand-of-the-year https://medipharmlabs.com/news-post/medipharm-labs-reports-first-quarter-results https://medipharmlabs.com/news-post/medipharm-labs-reports-first-quarter-results-completes-major-steps-towards-profitability-with-best-revenue-and-adjusted-ebitda-in-over-three-years https://medipharmlabs.com/news-post/medipharm-labs-reports-first-quarter-results-with-growth-in-sales-margin-and-ebitda https://medipharmlabs.com/news-post/medipharm-labs-reports-fourth-quarter-and-full-year-2021-results https://medipharmlabs.com/news-post/medipharm-labs-reports-fourth-quarter-and-full-year-2022-results https://medipharmlabs.com/news-post/medipharm-labs-reports-fourth-quarter-and-full-year-results https://medipharmlabs.com/news-post/medipharm-labs-reports-full-year-fourth-quarter-2024-results https://medipharmlabs.com/news-post/medipharm-labs-reports-second-quarter-results https://medipharmlabs.com/news-post/medipharm-labs-reports-second-quarter-results-closing-in-on-positive-adjusted-ebitda-1-as-gross-profit-continues-to-improve https://medipharmlabs.com/news-post/medipharm-labs-reports-second-quarter-results-with-doubling-of-revenue-and-record-margin-growth https://medipharmlabs.com/news-post/medipharm-labs-reports-third-quarter-results https://medipharmlabs.com/news-post/medipharm-labs-reports-third-quarter-results-2 https://medipharmlabs.com/news-post/medipharm-labs-reports-third-quarter-results-achieves-higher-gross-margin-moves-closer-to-profitability https://medipharmlabs.com/news-post/medipharm-labs-responds-to-dissident-shareholders-filing https://medipharmlabs.com/news-post/medipharm-labs-responds-to-fabricated-allegations-from-dissident-shareholder https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-first-quarter-2022-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-first-quarter-2023-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-first-quarter-2024-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-first-quarter-2025-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-fourth-quarter-and-full-year-2021-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-full-year-and-fourth-quarter-2023-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-full-year-and-fourth-quarter-2024-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-full-year-and-fourth-quarter-2025-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-second-quarter-2022-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-second-quarter-2025-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-third-quarter-2021-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-third-quarter-2022-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-third-quarter-2024-financial-results https://medipharmlabs.com/news-post/medipharm-labs-sets-date-to-report-third-quarter-2025-financial-results https://medipharmlabs.com/news-post/medipharm-labs-settles-an-outstanding-claim-for-9m https://medipharmlabs.com/news-post/medipharm-labs-strengthens-recreational-business-adding-flower-and-pre-rolls-to-portfolio-acquires-ip-from-canadian-consumer-favourite-shelter-cannabis-brands https://medipharmlabs.com/news-post/medipharm-labs-to-enter-new-market-with-costa-rica-supply-agreement https://medipharmlabs.com/news-post/medipharm-labs-to-sell-its-hope-facility-to-rubicon-organics-for-4-5m https://medipharmlabs.com/news-post/medipharm-labs-update-on-9m-settlement-agreement-all-tilray-shares-sold-and-converted-to-cash https://medipharmlabs.com/news-post/medipharm-reminds-shareholders-to-vote-in-advance-of-june-13-deadline https://medipharmlabs.com/news-post/medipharm-reports-third-quarter-2021-results-announces-new-ceo-to-start-today https://medipharmlabs.com/news-post/medipharm-strengthens-global-position-in-q2-2025-with-14-revenue-growth-and-50-increase-in-international-medical-cannabis https://medipharmlabs.com/news-post/medipharm-welcomes-news-from-the-u-s-government https://medipharmlabs.com/news-post/potential-health-benefits-and-risks-of-cannabis-what-the-medical-research-says https://medipharmlabs.com/news-post/the-bioavailability-of-cannabis-explained https://medipharmlabs.com/news-post/understanding-cannabinoids https://medipharmlabs.com/news-post/what-goes-in-a-cannabis-vape